January 2017 - Bioscience Americas

January 2017

Benefits of Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are advantageous over other stem cells types for a variety of reasons. First, they avoid the ethical issues that surround embryonic stem cell research. Second, repeated studies have found MSCs to be immuno-privileged, which make them an advantageous cell type for allogeneic transplantation. MSCs reduce both the risks of rejection and complications of transplantation. Third, there have been advances in the use of autologous mesenchymal stem cells to regenerate human tissues, including cartilage, meniscus, tendons, and bone [...]

Is Stem Cell Therapy Safe?

What do we know of the safety and efficacy of stem cell therapeutics? We are indebted to Cade Hildreth, CEO of BioInformant for this article and information. Over 50 years have passed since the discovery of hematopoietic stem cells (bone marrow transplantation to cure diseases such as leukemia), almost 20 years since the discovery of human embryonic stem cells (hESC), and 10 years since the discovery of induced pluripotent stem cells (iPS cells). There are also more than 5,000 stem cell [...]

Dr. Shekhar Challa Joins Bioscience Americas Board of Advisors

Bioscience Americas, LLC, a leading developer of autologous stem cell treatment centers, is pleased to announce that Dr. Shekhar K. Challa has joined its Board of Advisors. Dr. Challa is the co-founder of the Kansas Medical Clinic in Topeka, Kansas. The Clinic is a multi-specialty facility focused on gastroenterology, dermatology, pathology, and plastic surgery. Dr. Challa received his MD degree from Kakatiya Medical College in Andhra Pradesh, India. His internship and residency and fellowship were completed at Coney Island [...]

Bioscience Americas Names Dr. Firas Kara to its Board of Advisors

Bioscience Americas is pleased to announce that Dr. Firas M. Kara of Fort Wayne, Indiana has joined the Bioscience Americas Board of Advisors. Dr. Kara holds duel MD and PhD degrees from Heinrich Heine University in Düsseldorf, Germany. He completed a Residency in Internal Medicine at Berkshire Medical Center/ University of Massachusetts Medical School. Dr. Kara is currently specializing in interventional pain management with an emphasis on non-operative spine care. He believes in a comprehensive, compassionate approach to patient [...]